Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The New England Journal of Medicine
|
July 3, 1980
Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia
D Gangji, G H Reaman, S R Cohen, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1990
Penetration of ciprofloxacin into human pleural fluid
F Jacobs, M Marchal, P de Francquen, et al.
Gynecologic Oncology
|
June 25, 2002
Adoptive immunotherapy of ovarian carcinoma
A de Gramont, D Gangji, C Louvet, et al.
Oncology
|
January 1, 1985
Therapeutic effect of human recombinant interferon-alpha-2C in essential thrombocythaemia
T Velu, F Delwiche, D Gangji, et al.
European Journal of Cancer
|
February 1, 1978
Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group
P Alberto, M Rozencweig, D Gangji, et al.
Journal of the National Cancer Institute
|
March 1, 1982
Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys
J Blatt, P M Venner, R Riccardi, et al.
Journal De La Societe De Biologie
|
September 4, 2001
[Anti-tumor immunotherapy based on dendritic cells]
M Toungouz, M Lambermont, T Velu, et al.
The American Journal of Medicine
|
November 30, 1989
Randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia
D Gangji, F Jacobs, J de Jonckheer, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1986
Treatment of hairy-cell leukemia with recombinant alpha 2-interferon
Z N Berneman, G Gastl, D Gangji, et al.
British Journal of Clinical Pharmacology
|
January 1, 1984
Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol
D Gangji, M Juvent, G Niset, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The New England Journal of Medicine
|
July 3, 1980
Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia
D Gangji, G H Reaman, S R Cohen, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1990
Penetration of ciprofloxacin into human pleural fluid
F Jacobs, M Marchal, P de Francquen, et al.
Gynecologic Oncology
|
June 25, 2002
Adoptive immunotherapy of ovarian carcinoma
A de Gramont, D Gangji, C Louvet, et al.
Oncology
|
January 1, 1985
Therapeutic effect of human recombinant interferon-alpha-2C in essential thrombocythaemia
T Velu, F Delwiche, D Gangji, et al.
European Journal of Cancer
|
February 1, 1978
Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group
P Alberto, M Rozencweig, D Gangji, et al.
Journal of the National Cancer Institute
|
March 1, 1982
Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys
J Blatt, P M Venner, R Riccardi, et al.
Journal De La Societe De Biologie
|
September 4, 2001
[Anti-tumor immunotherapy based on dendritic cells]
M Toungouz, M Lambermont, T Velu, et al.
The American Journal of Medicine
|
November 30, 1989
Randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia
D Gangji, F Jacobs, J de Jonckheer, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1986
Treatment of hairy-cell leukemia with recombinant alpha 2-interferon
Z N Berneman, G Gastl, D Gangji, et al.
British Journal of Clinical Pharmacology
|
January 1, 1984
Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol
D Gangji, M Juvent, G Niset, et al.
Page
of 4